Xeroderma Pigmentosum Patient Experiences

计划入组 15 人 · 首次发布于 2010 年 5 月 14 日

Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum

计划入组 301 人 · 首次发布于 2002 年 9 月 23 日

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

计划入组 6 人 · 首次发布于 2021 年 12 月 16 日

group A Streptococcal vaccine

group A polysaccharide vaccine

group A streptococcus vaccine

NEURO DEVICE GROUP S A

Poland

N & S NEUROLOGY CENTER, A MEDICAL GROUP, INC.

United States

A&A SMALL CHANGES HANDYPEOPLE

United States

Niagen Bioscience Launches NB4168, a Proprietary NAD+ Precursor, as First Pharmaceutical Candidate for Ataxia Telangiectasia

The Impact of Chloro and Methoxy Groups on Small Molecule Drug Discovery

Novel Agents Identified for Osteosarcoma Treatment in Children and Young Adults